SCHEMBL25958491

SCHEMBL25958491

CCCn1nncc1C(=O)OC

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ TSHR P16473 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ HCAR3 P49019 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ RAB9A P51151 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ TOP2A P11388 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ MTNR1A P48039 1/20 0.35
▸ MTNR1B P49286 1/20 0.35
▸ NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1412495 0.86 KDM4E (0.37) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL23989841 0.85 KDM4E (0.36) KDM4EALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL1029619 0.84 MAPK1 (0.41) KDM4ESMN1; SMN2RAB9ANPC1
Bicarbonate SCHEMBL7485088 0.84 KDM4E (0.34) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL23991151 0.83 CNR1 (0.37) KDM4EALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL23985455 0.81 KDM4C (0.34) KDM4ESMN1; SMN2L3MBTL1RAB9AMEN1
SCHEMBL24103007 0.81 HCAR3 (0.45) KDM4EHCAR3L3MBTL1TOP2ANPC1
SCHEMBL30420448 0.79 HCAR3 (0.38) KDM4EALDH1A1LMNAHCAR3L3MBTL1
SCHEMBL1412690 0.77 KDM4E (0.42) KDM4EALDH1A1HPGDLMNANPSR1
SCHEMBL23989504 0.76 GRM2 (0.39) LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230250079-A1 SMALL MOLECULE MODULATORS OF IL-17 LEO PHARMA A/S (DK) 2023-08-10 — — US disclosed
US-20230250079-A1 SMALL MOLECULE MODULATORS OF IL-17 LEO PHARMA A/S (DK) 2023-08-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230250079-A1 SMALL MOLECULE MODULATORS OF IL-17 IL17A, IL2, IL23R KDM4E 1325/4885ALDH1A1 490/4885MAPT 521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback